Research And Views Archives | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Archives... Don't Miss Anything, Ever!

Here you will find all the research and views that we post on Equitymaster. Use the tools to customize the results to suit your preference!


















Authors
 

APTE AMALGAMATIONS Share price, NSE/BSE Forecast News and Quotes| Equitymaster

Jun 22, 2021 | Updated on Jun 22, 2021

APTE AMALGAMATIONS: Get the latest APTE AMALGAMATIONS Share price and stock price updates, live NSE/BSE share price, share market reports, financial report, balance sheet, price charts, financial forecast news and quotes only at Equitymaster.com.

Procter & Gamble Health Share price, NSE/BSE Forecast News and Quotes| Equitymaster

Jun 22, 2021 | Updated on Jun 22, 2021

Procter & Gamble Health: Get the latest Procter & Gamble Health Share price and stock price updates, live NSE/BSE share price, share market reports, financial report, balance sheet, price charts, financial forecast news and quotes only at Equitymaster.com.

Novartis: Margins on upward spiral

Jan 28, 2002

Novartis India has declared encouraging results for 3QFY02. Net profits have leapfrogged by more than 100% on a back of sharp spurt in operating margins. However, the growth in topline has slowed down considerably with just 2% growth in the concerned quarter. Subsequent to completion of the demerger of its agribusiness and amalgamation of Ciba CKD Biochem, the company has recast prior period results. The results are thus comparable on a year to year basis.

Novartis: Operating margins disappoints

Jul 27, 2001

Novartis India has posted a net profit of Rs 92 m for 1QFY02 as against Rs 186 m in the corresponding quarter last year. However, the figures for the year are not comparable as the company demerged its agrochemical business, which resulted in this sharp decline in turnover and profits. The company also decided to exit the lens and lens care business of CibaVision with effect from December 2000 due to unviability of the same.

Novartis FY01 net at Rs 526 m

Jun 29, 2001

Novartis India has posted a net profit of Rs 526 m for FY01 as against Rs 1,034 m for FY00. However, the figures for the year are not comparable as the company demerged its agrochemical business, which resulted in this sharp decline in turnover and profits. Again, in the current year, the management also decided to exit the lens and lens care business of CibaVision with effect from December 2000. This is based on the ground that the business did not reach a critical mass within a reasonable peri


India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

MARKET STATS